Cost analysis: Mohs micrographic surgery

Dermatologic Surgery

Volumn 38, Issue 4, 2012, Pages 585-594

  Ravitskiy, Larisa ^a   Brodland, David G ^b   Zitelli, John A ^b  

^a THE OHIO STATE UNIVERSITY WEXNER MEDICAL CENTER   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CANCER RECURRENCE; CANCER STAGING; COST BENEFIT ANALYSIS; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MOHS MICROGRAPHIC SURGERY; PRIORITY JOURNAL; SKIN CANCER; STANDARD SURGICAL EXCISION; SURGICAL TECHNIQUE; TUMOR BIOPSY;

COSTS AND COST ANALYSIS; FEMALE; HUMANS; MALE; MOHS SURGERY; SKIN NEOPLASMS;

EID: 84859439041     PISSN: 10760512     EISSN: 15244725     Source Type: Journal    
DOI: 10.1111/j.1524-4725.2012.02341.x     Document Type: Article

References (42)

1. Miller DL, Weinstock MA. Nonmelanoma skin cancer in the United States: incidence. J Am Acad Dermatol 1994;30:774-8. (Pubitemid 24157120)
2. American Cancer Society. 2001 [on-line]. Available from: http://www.cancer.org/downloads/STT/F&F2001.pdf Accessed August 10, 2009.
3. Essers BA, Dirksen CD, Nieman FH, Smeets NW, et al. Costeffectiveness of Mohs micrographic surgery vs surgical excision for basal cell carcinoma of the face. Arch Dermatol 2006;142:187-94. (Pubitemid 43276530)
4. Bialy TL, Whalen J, Veledar E, Lafreniere D, et al. Mohs micrographic surgery vs traditional surgical excision: a cost comparison analysis. Arch Dermatol 2004;140:736-42. (Pubitemid 38747292)
5. Smeets NW, Krekels GA, Ostertag JU, Essers BA, et al. Surgical excision vs Mohs' micrographic surgery for basal-cell carcinoma of the face: randomised controlled trial. Lancet 2004;364:1766-72. (Pubitemid 39488061)
6. Otley CC. Cost-effectiveness of Mohs micrographic surgery vs surgical excision for basal cell carcinoma of the face. Arch Dermatol 2006;142:1235; author reply -6.
7. CMS. Federal Register. 1991;56:59602.
8. CMS. Federal Registry. 2007;72:66254-5.
9. National Comprehensive Cancer NetworkAvailable from: http://www.nccn.org/ index.asp Accessed August 10, 2009.
10. Cataldo PA, Stoddard PB, Reed WP. Use of frozen section analysis in the treatment of basal cell carcinoma. Am J Surg 1990;159:561-3. (Pubitemid 20180121)
11. Rowe DE, Carroll RJ, Day CL, Jr. Long-term recurrence rates in previously untreated (primary) basal cell carcinoma: implications for patient follow-up. J Dermatol Surg Oncol 1989;15:315-28. (Pubitemid 19085793)
12. Cook J, Zitelli JA. Mohs micrographic surgery: a cost analysis. J Am Acad Dermatol 1998;39:698-703. (Pubitemid 28519021)
13. Downes RN, Walker NP, Collin JR. Micrographic (MOHS') surgery in the management of periocular basal cell epitheliomas. Eye 1990;4 (Pt 1):160-8. (Pubitemid 20304632)
14. Bumsted RM, Ceilley RI. Auricular malignant neoplasms. Identification of high-risk lesions and selection of method of reconstruction. Arch Otolaryngol 1982;108:225-31. (Pubitemid 12148000)
15. Bentkover SH, Grande DM, Soto H, Kozlicak BA, et al. Excision of head and neck basal cell carcinoma with a rapid, cross-sectional, frozen-section technique. Arch Facial Plast Surg 2002;4:114-9.
16. Rogers HW, Coldiron BM. A relative value unit-based cost comparison of treatment modalities for nonmelanoma skin cancer: effect of the loss of the Mohs multiple surgery reduction exemption. J Am Acad Dermatol 2009;61:96-103.
17. Alexiades-Armenakas M, Ramsay D, Kopf AW. The appropriateness of curettage and electrodesiccation for the treatment of basal cell carcinomas. Arch Dermatol 2000;136:800. (Pubitemid 30407448)
18. Kopf AW, Bart RS, Schrager D, Lazar M, Popkin GL. Curettage- electrodesiccation treatment of basal cell carcinomas. Arch Dermatol 1977;113:439-43. (Pubitemid 8071603)
19. Thissen MR, Neumann MH, Schouten LJ. A systematic review of treatment modalities for primary basal cell carcinomas. Arch Dermatol 1999;135:1177-83. (Pubitemid 29493277)
20. Miller SJ, Alam M, Andersen J, Berg D, et al. Basal cell and squamous cell skin cancers. J Natl Compr Canc Netw 2007;5:506-29. (Pubitemid 46815212)
21. Rodriguez-Vigil T, Vazquez-Lopez F, Perez-Oliva N. Recurrence rates of primary basal cell carcinoma in facial risk areas treated with curettage and electrodesiccation. J Am Acad Dermatol 2007;56:91-5. (Pubitemid 44969296)
22. Gollnick H, Barona CG, Frank RG, Ruzicka T, et al. Recurrence rate of superficial basal cell carcinoma following successful treatment with imiquimod 5% cream: interim 2-year results from an ongoing 5-year follow-up study in Europe. Eur J Dermatol 2005;15:374-81. (Pubitemid 41337416)
23. Geisse J, Caro I, Lindholm J, Golitz L, et al. Imiquimod 5% cream for the treatment of superficial basal cell carcinoma: results from two phase III, randomized, vehicle-controlled studies. J Am Acad Dermatol 2004;50:722-33. (Pubitemid 38580549)
24. Aldara (Imiquimod) NDA 020723: Efficacy Supplement with Clinical Data to Support (supplement 020). 03/22/2007. Available from: http://www.accessdata.fda. gov/drugsatfda-docs/label/2007/020723s020lbl.pdf Accessed December 1, 2009.
25. Hernandez-Machin B, Borrego L, Gil-Garcia M, Hernandez BH. Office-based radiation therapy for cutaneous carcinoma: evaluation of 710 treatments. Int J Dermatol 2007;46:453-9. (Pubitemid 46711421)
26. Schulte KW, Lippold A, Auras C, Bramkamp G, et al. Soft xray therapy for cutaneous basal cell and squamous cell carcinomas. J Am Acad Dermatol 2005;53:993-1001. (Pubitemid 41677325)
27. Caccialanza M, Piccinno R, Grammatica A. Radiotherapy of recurrent basal and squamous cell skin carcinomas: a study of 249 re-treated carcinomas in 229 patients. Eur J Dermatol 2001;11:25-8. (Pubitemid 32150374)
28. Bisson MA, Dunkin CS, Suvarna SK, Griffiths RW. Do plastic surgeons resect basal cell carcinomas too widely? A prospective study comparing surgical and histological margins. Br J Plast Surg 2002;55:293-7. (Pubitemid 34830857)
29. Kumar P, Orton CI, McWilliam LJ, Watson S. Incidence of incomplete excision in surgically treated basal cell carcinoma: a retrospective clinical audit. Br J Plast Surg 2000;53:563-6.
30. Wilson AW, Howsam G, Santhanam V, Macpherson D, et al. Surgical management of incompletely excised basal cell carcinomas of the head and neck. Br J Oral Maxillofac Surg 2004;42:311-4. (Pubitemid 38842813)
31. Hussain M, Earley MJ. The incidence of incomplete excision in surgically treated basal cell carcinoma: a retrospective clinical audit. Ir Med J 2003;96:18-20. (Pubitemid 36701051)
32. Dieu T, Macleod AM. Incomplete excision of basal cell carcinomas: a retrospective audit. ANZ J Surg 2002;72:219-21. (Pubitemid 34298049)
33. Griffiths RW. Audit of histologically incompletely excised basal cell carcinomas: recommendations for management by reexcision. Br J Plast Surg 1999;52:24-8. (Pubitemid 29080256)
34. Bogdanov-Berezovsky A, Cohen AD, Glesinger R, Cagnano E, et al.Risk factors for incomplete excision of basal cell carcinomas. Acta Derm Venereol 2004;84:44-7. (Pubitemid 38168362)
35. Sussman LA, Liggins DF. Incompletely excised basal cell carcinoma: a management dilemma? Aust N Z J Surg 1996;66:276-8. (Pubitemid 26163510)
36. Fleischer AB Jr, Feldman SR, Barlow JO, Zheng B, et al. The specialty of the treating physician affects the likelihood of tumor-free resection margins for basal cell carcinoma: results from a multi-institutional retrospective study. J Am Acad Dermatol 2001;44:224-30. (Pubitemid 32172183)
37. Hallock GG, Lutz DA. A prospective study of the accuracy of the surgeon's diagnosis and significance of positive margins in nonmelanoma skin cancers. Plast Reconstr Surg 2001;107:942-7. (Pubitemid 32233431)
38. Farhi D, Dupin N, Palangie A, Carlotti A, et al. Incomplete excision of basal cell carcinoma: rate and associated factors among 362 consecutive cases. Dermatol Surg 2007;33:1207-14. (Pubitemid 47508668)
39. Su SY, Giorlando F, Ek EW, Dieu T. Incomplete excision of basal cell carcinoma: a prospective trial. Plast Reconstr Surg 2007;120:1240-8. (Pubitemid 47493946)
40. Nagore E, Grau C, Molinero J, Fortea JM. Positive margins in basal cell carcinoma: relationship to clinical features and recurrence risk. A retrospective study of 248 patients. J Eur Acad Dermatol Venereol 2003;17:167-70. (Pubitemid 36416782)
41. Silverman MK, Kopf AW, Bart RS, Grin CM, et al. Recurrence rates of treated basal cell carcinomas. Part 3: surgical excision. J Dermatol Surg Oncol 1992;18:471-6.
42. Brodland DG, Zitelli JA. Surgical margins for excision of primary cutaneous squamous cell carcinoma. J Am Acad Dermatol 1992;27:241-8.